SIEMENS HEALTHINEERS AG (SHL.DE) Fundamental Analysis & Valuation
FRA:SHL • DE000SHL1006
Current stock price
38.47 EUR
+0.13 (+0.34%)
Last:
This SHL.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. SHL.DE Profitability Analysis
1.1 Basic Checks
- SHL had positive earnings in the past year.
- In the past year SHL had a positive cash flow from operations.
- In the past 5 years SHL has always been profitable.
- In the past 5 years SHL always reported a positive cash flow from operatings.
1.2 Ratios
- The Return On Assets of SHL (4.79%) is better than 66.67% of its industry peers.
- SHL has a Return On Equity of 11.50%. This is in the better half of the industry: SHL outperforms 74.60% of its industry peers.
- SHL's Return On Invested Capital of 7.88% is fine compared to the rest of the industry. SHL outperforms 66.67% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for SHL is below the industry average of 10.15%.
- The last Return On Invested Capital (7.88%) for SHL is above the 3 year average (6.28%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 11.5% | ||
| ROIC | 7.88% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
1.3 Margins
- The Profit Margin of SHL (9.10%) is better than 68.25% of its industry peers.
- SHL's Profit Margin has been stable in the last couple of years.
- Looking at the Operating Margin, with a value of 13.49%, SHL is in the better half of the industry, outperforming 61.90% of the companies in the same industry.
- SHL's Operating Margin has been stable in the last couple of years.
- SHL's Gross Margin of 38.44% is on the low side compared to the rest of the industry. SHL is outperformed by 82.54% of its industry peers.
- SHL's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.49% | ||
| PM (TTM) | 9.1% | ||
| GM | 38.44% |
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
2. SHL.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so SHL is still creating some value.
- Compared to 1 year ago, SHL has less shares outstanding
- Compared to 5 years ago, SHL has more shares outstanding
- The debt/assets ratio for SHL has been reduced compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.90 indicates that SHL is not a great score, but indicates only limited risk for bankruptcy at the moment.
- SHL's Altman-Z score of 1.90 is on the low side compared to the rest of the industry. SHL is outperformed by 63.49% of its industry peers.
- The Debt to FCF ratio of SHL is 6.56, which is on the high side as it means it would take SHL, 6.56 years of fcf income to pay off all of its debts.
- SHL has a Debt to FCF ratio of 6.56. This is comparable to the rest of the industry: SHL outperforms 52.38% of its industry peers.
- A Debt/Equity ratio of 0.53 indicates that SHL is somewhat dependend on debt financing.
- SHL's Debt to Equity ratio of 0.53 is on the low side compared to the rest of the industry. SHL is outperformed by 60.32% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 6.56 | ||
| Altman-Z | 1.9 |
ROIC/WACC1.26
WACC6.27%
2.3 Liquidity
- SHL has a Current Ratio of 1.04. This is a normal value and indicates that SHL is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.04, SHL is doing worse than 76.19% of the companies in the same industry.
- SHL has a Quick Ratio of 1.04. This is a bad value and indicates that SHL is not financially healthy enough and could expect problems in meeting its short term obligations.
- Looking at the Quick ratio, with a value of 0.72, SHL is doing worse than 73.02% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.04 | ||
| Quick Ratio | 0.72 |
3. SHL.DE Growth Analysis
3.1 Past
- The Earnings Per Share has been growing slightly by 1.33% over the past year.
- The Earnings Per Share has been growing by 11.29% on average over the past years. This is quite good.
- SHL shows a small growth in Revenue. In the last year, the Revenue has grown by 2.76%.
- SHL shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 10.08% yearly.
EPS 1Y (TTM)1.33%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%-21.57%
Revenue 1Y (TTM)2.76%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-1.46%
3.2 Future
- The Earnings Per Share is expected to grow by 8.69% on average over the next years. This is quite good.
- Based on estimates for the next years, SHL will show a small growth in Revenue. The Revenue will grow by 5.34% on average per year.
EPS Next Y-2.64%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
EPS Next 5Y8.69%
Revenue Next Year1.77%
Revenue Next 2Y3.91%
Revenue Next 3Y4.63%
Revenue Next 5Y5.34%
3.3 Evolution
- When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. SHL.DE Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 16.87, the valuation of SHL can be described as correct.
- Based on the Price/Earnings ratio, SHL is valued cheaper than 85.71% of the companies in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 27.38, SHL is valued a bit cheaper.
- A Price/Forward Earnings ratio of 14.53 indicates a correct valuation of SHL.
- SHL's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. SHL is cheaper than 77.78% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of SHL to the average of the S&P500 Index (38.20), we can say SHL is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.87 | ||
| Fwd PE | 14.53 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SHL indicates a somewhat cheap valuation: SHL is cheaper than 61.90% of the companies listed in the same industry.
- SHL's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. SHL is cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 19.42 | ||
| EV/EBITDA | 12.38 |
4.3 Compensation for Growth
- The decent profitability rating of SHL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)1.49
EPS Next 2Y5.26%
EPS Next 3Y7.63%
5. SHL.DE Dividend Analysis
5.1 Amount
- SHL has a Yearly Dividend Yield of 2.68%. Purely for dividend investing, there may be better candidates out there.
- SHL's Dividend Yield is rather good when compared to the industry average which is at 1.23. SHL pays more dividend than 82.54% of the companies in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.82, SHL pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.68% |
5.2 History
- The dividend of SHL has a limited annual growth rate of 4.38%.
Dividend Growth(5Y)4.38%
Div Incr Years1
Div Non Decr Years7
5.3 Sustainability
- 50.31% of the earnings are spent on dividend by SHL. This is a bit on the high side, but may be sustainable.
- SHL's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP50.31%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
SHL.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:SHL (4/16/2026, 2:02:58 PM)
38.47
+0.13 (+0.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-05 2026-02-05/dmh
Earnings (Next)05-07 2026-05-07
Inst Owners13.8%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap43.39B
Revenue(TTM)23.30B
Net Income(TTM)2.12B
Analysts79.29
Price Target54.55 (41.8%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.68% |
Yearly Dividend0.95
Dividend Growth(5Y)4.38%
DP50.31%
Div Incr Years1
Div Non Decr Years7
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.86%
Min EPS beat(2)-13.74%
Max EPS beat(2)-3.98%
EPS beat(4)1
Avg EPS beat(4)-1.6%
Min EPS beat(4)-13.74%
Max EPS beat(4)13.36%
EPS beat(8)4
Avg EPS beat(8)1.31%
EPS beat(12)6
Avg EPS beat(12)0.88%
EPS beat(16)9
Avg EPS beat(16)1.56%
Revenue beat(2)1
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-4.1%
Max Revenue beat(2)0.15%
Revenue beat(4)2
Avg Revenue beat(4)-1.11%
Min Revenue beat(4)-4.1%
Max Revenue beat(4)0.27%
Revenue beat(8)3
Avg Revenue beat(8)-1.06%
Revenue beat(12)4
Avg Revenue beat(12)-0.67%
Revenue beat(16)7
Avg Revenue beat(16)-0.39%
PT rev (1m)-0.88%
PT rev (3m)-3.63%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)-12.1%
EPS NY rev (1m)0.75%
EPS NY rev (3m)-2.33%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-2.36%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-1.04%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.87 | ||
| Fwd PE | 14.53 | ||
| P/S | 1.86 | ||
| P/FCF | 19.42 | ||
| P/OCF | 14.26 | ||
| P/B | 2.35 | ||
| P/tB | N/A | ||
| EV/EBITDA | 12.38 |
EPS(TTM)2.28
EY5.93%
EPS(NY)2.65
Fwd EY6.88%
FCF(TTM)1.98
FCFY5.15%
OCF(TTM)2.7
OCFY7.01%
SpS20.65
BVpS16.34
TBVpS-4.52
PEG (NY)N/A
PEG (5Y)1.49
Graham Number28.9504 (-24.75%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.79% | ||
| ROE | 11.5% | ||
| ROCE | 10.26% | ||
| ROIC | 7.88% | ||
| ROICexc | 8.62% | ||
| ROICexgc | 53.82% | ||
| OM | 13.49% | ||
| PM (TTM) | 9.1% | ||
| GM | 38.44% | ||
| FCFM | 9.59% |
ROA(3y)4.09%
ROA(5y)4.11%
ROE(3y)10.3%
ROE(5y)10.39%
ROIC(3y)6.28%
ROIC(5y)6.22%
ROICexc(3y)6.75%
ROICexc(5y)6.62%
ROICexgc(3y)33.94%
ROICexgc(5y)34.43%
ROCE(3y)8.18%
ROCE(5y)8.09%
ROICexgc growth 3Y11.98%
ROICexgc growth 5Y11.06%
ROICexc growth 3Y9.08%
ROICexc growth 5Y-1.26%
OM growth 3Y0.16%
OM growth 5Y0.1%
PM growth 3Y-0.76%
PM growth 5Y-1.23%
GM growth 3Y1.02%
GM growth 5Y0.02%
F-Score7
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.53 | ||
| Debt/FCF | 6.56 | ||
| Debt/EBITDA | 2.22 | ||
| Cap/Depr | 62.76% | ||
| Cap/Sales | 3.47% | ||
| Interest Coverage | 7.31 | ||
| Cash Conversion | 68.7% | ||
| Profit Quality | 105.47% | ||
| Current Ratio | 1.04 | ||
| Quick Ratio | 0.72 | ||
| Altman-Z | 1.9 |
F-Score7
WACC6.27%
ROIC/WACC1.26
Cap/Depr(3y)57.95%
Cap/Depr(5y)60.43%
Cap/Sales(3y)3.49%
Cap/Sales(5y)3.63%
Profit Quality(3y)107.05%
Profit Quality(5y)106.62%
High Growth Momentum
Growth
EPS 1Y (TTM)1.33%
EPS 3Y1.29%
EPS 5Y11.29%
EPS Q2Q%-21.57%
EPS Next Y-2.64%
EPS Next 2Y5.26%
EPS Next 3Y7.63%
EPS Next 5Y8.69%
Revenue 1Y (TTM)2.76%
Revenue growth 3Y2.49%
Revenue growth 5Y10.08%
Sales Q2Q%-1.46%
Revenue Next Year1.77%
Revenue Next 2Y3.91%
Revenue Next 3Y4.63%
Revenue Next 5Y5.34%
EBIT growth 1Y7.86%
EBIT growth 3Y2.65%
EBIT growth 5Y10.19%
EBIT Next Year31.85%
EBIT Next 3Y17.07%
EBIT Next 5Y13.29%
FCF growth 1Y40.04%
FCF growth 3Y18%
FCF growth 5Y14.63%
OCF growth 1Y28.66%
OCF growth 3Y12.15%
OCF growth 5Y12.87%
SIEMENS HEALTHINEERS AG / SHL.DE Fundamental Analysis FAQ
What is the fundamental rating for SHL stock?
ChartMill assigns a fundamental rating of 5 / 10 to SHL.DE.
Can you provide the valuation status for SIEMENS HEALTHINEERS AG?
ChartMill assigns a valuation rating of 5 / 10 to SIEMENS HEALTHINEERS AG (SHL.DE). This can be considered as Fairly Valued.
What is the profitability of SHL stock?
SIEMENS HEALTHINEERS AG (SHL.DE) has a profitability rating of 6 / 10.
What is the earnings growth outlook for SIEMENS HEALTHINEERS AG?
The Earnings per Share (EPS) of SIEMENS HEALTHINEERS AG (SHL.DE) is expected to decline by -2.64% in the next year.
Is the dividend of SIEMENS HEALTHINEERS AG sustainable?
The dividend rating of SIEMENS HEALTHINEERS AG (SHL.DE) is 6 / 10 and the dividend payout ratio is 50.31%.